Haemorrhoidal disease (HD) is one of the most common anorectal conditions, with a prevalence ranging between 4% and 36% of the population. Depending on its severity, HD can be effectively treated with medical and office-based procedures such as rubber-band ligation or sclerotherapy or various surgical approaches. Sclerotherapy has been described for treating Grade I–III HD. The injection of a sclerosing agent such as polidocanol provokes an inflammatory reaction with subsequent necrosis, fibrosis and fixation of the haemorrhoidal tissue. The success rate of sclerotherapy varies depending on the definition of success, the type of sclerosing agent injected and the degree of HD.

The use of sclerotherapy with polidocanol foam in the treatment of second-degree haemorrhoidal disease – a video vignette / Lobascio, P.; Minafra, M.; Laforgia, R.; Giove, C.; Trompetto, M.; Gallo, G.. - In: COLORECTAL DISEASE. - ISSN 1462-8910. - 21:2(2019), pp. 244-245. [10.1111/codi.14498]

The use of sclerotherapy with polidocanol foam in the treatment of second-degree haemorrhoidal disease – a video vignette

Gallo G.
Ultimo
2019

Abstract

Haemorrhoidal disease (HD) is one of the most common anorectal conditions, with a prevalence ranging between 4% and 36% of the population. Depending on its severity, HD can be effectively treated with medical and office-based procedures such as rubber-band ligation or sclerotherapy or various surgical approaches. Sclerotherapy has been described for treating Grade I–III HD. The injection of a sclerosing agent such as polidocanol provokes an inflammatory reaction with subsequent necrosis, fibrosis and fixation of the haemorrhoidal tissue. The success rate of sclerotherapy varies depending on the definition of success, the type of sclerosing agent injected and the degree of HD.
2019
sclerotherapy; haemorrhoidal disease; polidocanol foam
01 Pubblicazione su rivista::01i Case report
The use of sclerotherapy with polidocanol foam in the treatment of second-degree haemorrhoidal disease – a video vignette / Lobascio, P.; Minafra, M.; Laforgia, R.; Giove, C.; Trompetto, M.; Gallo, G.. - In: COLORECTAL DISEASE. - ISSN 1462-8910. - 21:2(2019), pp. 244-245. [10.1111/codi.14498]
File allegati a questo prodotto
File Dimensione Formato  
Lobascio_The-use-of-sclerotherapy_2019.pdf

solo gestori archivio

Tipologia: Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza: Tutti i diritti riservati (All rights reserved)
Dimensione 117.41 kB
Formato Adobe PDF
117.41 kB Adobe PDF   Contatta l'autore

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/1661102
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 13
  • ???jsp.display-item.citation.isi??? 13
social impact